Journal article

Chewing the fat over statins: consumer concerns about lipid-lowering medication

1 Aug 2017
Description

Background

The objective of this article was to explore the information needs of consumers using statins.

Methods

Calls made to a national medicines call centre in Australia were analysed. Where question narratives were available electronically (n = 1486), the main concerns were identified using a coding scheme. Subsequently, we evaluated whether these concerns were addressed in the medication leaflet.

Results

The most common concerns were about side effects (36%) and interactions (28%). Concerns about side effects related to musculoskeletal (27%), gastrointestinal (12%) and skin problems (5%). Concerns about interactions included other medicines (49%), complementary and alternative medicines (CAMs; 39%) and grapefruit (6%). Additional questions related to differences between treatments (12%) and dosage (8%). Most topics were mentioned in the medication leaflet, but strategies to manage these concerns were lacking.

Discussion

When prescribing statins, information about common side effects, when symptoms require action, and interactions with other medicines, especially CAMs, should be addressed and tailored to the patient.

Publication Details
Volume: 
46
Issue: 
8
Pagination: 
594-601
License Type: 
All Rights Reserved
Peer Reviewed: 
Yes
Published year only: 
2017
210
Share
Share
Subject Areas
Geographic Coverage
Advertisement